Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q4 FY2022 Earnings Presentation
27 slides from Apollo Hospitals Enterprise's earnings presentation, May 26, 2022
Slide 1: Apollo Hospitals Enterprise Limited - Regulation 30 disclosure
APOLLO HOSPITALS ENTERPRISE LIMITED 26" May 2022 The Secretary, ie ry. ollo HOSPITALS TOUCHING LIVES CIN : L85110TN1979PLC008035 The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Exchange Plaza, Sth Floor Plot No.C/1,
Slide 2: Earnings Update Q4 FY 2022
EARNINGS UPDATE Q4 FY 2022 1
Slide 3: Disclaimer
DISCLAIMER • No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 4: Key Highlights
Key Highlights HIGHLIGHTS CONSOLIDATED FINANCIAL OPERATIONAL PARAMETERS - PERFORMANCE HOSPITALS & PHARMACIES APOLLO 24/7 APOLLO HEALTH & LIFESTYLE LTD ANNEXURE 3
Slide 5: Highlights
HIGHLIGHTS i
Slide 6: Highlights: Financial Performance Q4 FY22
HIGHLIGHTS Q4 FY22 Consolidated Revenues of ` 35,464 mio (growth of 24% yoy). Q4 FY22 Consolidated EBITDA (Post Ind AS 116) of ` 4,632 mio. Financial New Hospitals (excl Proton) reported an EBITDA of ` 826 mio in Q4 FY22 as compared to an EBITDA of ` 677 mio in Q4 FY21. Performance Q4 FY22 P
Slide 7: Highlights: Capacity and Medical Initiatives
HIGHLIGHTS 71 hospitals with total bed capacity of 9,911 beds as on March 31, 2022. 44 owned hospitals including JVs/ Subsidiaries and Associates with 8,538 beds. 11 Day care/ short surgical stay centres with 244 beds and 11 Cradles with 278 beds. Capacity 5 Managed hospitals with 851 beds.
Slide 8: COVID Testing and Treatment – FY22
COVID TESTING AND TREATMENT – FY22 ‘Project Stay I’ saw success with over 25,000 600+ 38,600 + room nights. Dedicated beds In -Patients 3,100+ Stay I Our effort in the Home care segment enabled us to move into 1,51,000 homes, (of which COVID care was at 51,000 homes) and provide medically superv
Slide 9: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE
Slide 10: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE TOTAL (` mio) Q4 FY 21 Q4 FY 22 yoy (%) FY 21 FY 22 yoy (%) Total Revenues 28,680 35,464 23.7% 105,600 146,626 38.9% EBITDA (Post Ind AS 116) 4,118 4,632 12.5% 11,374 21,851 92.1% margin (%) 14.4% 13.1% -130 bps 10.8% 14.9% 413 bps EBIT 2,734 2,968 8.6% 5,643 15,84
Slide 11: Mature & New Breakup – Q4 FY22
CONSOLIDATED FINANCIAL PERFORMANCE MATURE & NEW BREAKUP – Q4 FY22 (` mio) Healthcare Key Highlights Healthcare Healthcare Serv *Health Co Serv Serv Group Proton & Pharmacy AHLL Consol HCS revenue grew by 21% in Q4FY22 Group Group (New & Distribution (Mature) (Total) Others) Hospitals 29 14 1 44 Oper
Slide 12: Mature & New Breakup – FY22
CONSOLIDATED FINANCIAL PERFORMANCE MATURE & NEW BREAKUP – FY22 (` mio) Healthcare Healthcare Serv Healthcare *Health Co Key Highlights Serv Serv Group Proton & Pharmacy AHLL Consol Group Group (Mature) (New & (Total) Distribution HCS revenue grew by 60% in FY22 Others) Hospitals 29 14 1 44 Operating
Slide 13: Operational Parameters - Hospitals & Pharmacies
OPERATIONAL PARAMETERS - HOSPITALS & PHARMACIES
Slide 14: Operational Parameters - Hospitals
OPERATIONAL PARAMETERS - HOSPITALS (` mio) Tamilnadu Region AP, Telengana Region Karnataka Region Significant Subs/JVs/associates Total (6) Others (4) (Chennai & others) (1) (Hyderabad & others) (2) (Bangalore & others) (3) (5) Particulars FY 21 FY 22 yoy (%) FY 21 FY 22 yoy (%) FY 21 FY 22 yoy (%)
Slide 15: Pharmacy Distribution & Health Co
PHARMACY DISTRIBUTION & HEALTH CO (` mio) Health Co & Pharmacy Distribution Q4 FY 21 Q4 FY 22 yoy (%) FY 21 FY 22 yoy (%) Revenue 11,187 13,745 22.9% 48,760 53,610 9.9% EBITDA (Post Ind AS 116)** 811 1,027 26.6% 3,932 4,089 4.0% margin (%) 7.3% 7.5% 22 bps 8.1% 7.6% -44 bps *Pharmacy Distribution fr
Slide 16: Apollo 24/7
APOLLO 24/7 i
Slide 17: Apollo 24x7 – India's Largest Omni-Channel Healthcare Platform
APOLLO 24X7 – INDIA’S LARGEST OMNI-CHANNEL HEALTHCARE PLATFORM LEVERAGING PHYSICAL NETWORK Distinctive digital 5 ecosystem … 4 Condition 6 management Digital services Online Health diagnostic predictor 3 booking 7 Well-being Part of Virtual doctor companion consultation Apollo 24/7 2 Online 8 Health
Slide 18: Distinctive digital ecosystem coupled with network and capabilities
Distinctive digital ecosystem… … coupled with adequate network and capabilities Cumulative upto 31st March 2022 Physical network & capabilities ~14 Lakh+ 1 2 3 Doctors across 3mm+ Annual Online Consults Diagnostic centers Hospitals & clinics chronic patients ~14Mn completed 4 5 Registrations Leverag
Slide 19: Apollo HealthCo
APOLLO HEALTHCO Reorganization through Slump Sale AHEL (Listed) • Apollo 24/7 represents Apollo Group’s transformational journey to creating “India’s Largest Omnichannel Digital Healthcare Platform” that: Backend combines the strengths of Apollo Group’s offline healthcare Healthcare Pharmacy + lea
Slide 20: Apollo Health & Lifestyle Ltd
APOLLO HEALTH & LIFESTYLE LTD
Slide 21: AHLL – Q4 FY22
AHLL – Q4 FY22 (` mio) Q4 FY22 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Key Highlights Network 254 1228 29 95 90 8 15 11 Footfalls/Day* 2894 14847 391 160 1358 34 27 66 AHLL reported Gross ARPP (Rs.)* 1484 798 2864 6641 1529 96520 39989 106769 • EBITDA of ` 371 mio as
Slide 22: AHLL – FY22
AHLL –FY22 (` mio) FY22 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Key Highlights Network 254 1228 29 95 90 8 15 11 Footfalls/Day* 5818 13409 383 148 1227 41 20 67 AHLL reported Gross ARPP (Rs.)* 1282 760 2863 6486 1515 100398 38652 104185 • EBITDA of ` 1,966 mio as comp
Slide 23: Annexure
ANNEXURE i
Slide 24: Annexure 1: Standalone Financial Performance
ANNEXURE 1 :STANDALONE FINANCIAL PERFORMANCE (` mio) TOTAL Q4 FY 21 Q4 FY 22 yoy (%) FY 21 FY 22 yoy (%) Revenue 12,913 14,207 10.0% 46,539 60,983 31.0% Operative Expenses 3,577 4,153 16.1% 12,226 19,293 57.8% Employee Expenses 2,702 2,709 0.3% 12,179 11,505 -5.5% Administrative & Other Expenses 3,8
Slide 25: Annexure 2: Ind AS 116 Impact on P&L and Balance Sheet
ANNEXURE 2 : IND AS - 116 IMPACT ON P&L AND BALANCE SHEET – FY22 (` mio) AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Revenue - Right of use Revenue Right of use Asset as of 5,340 Asset as of 10,729 Other 893 Other expe
Slide 26: Annexure 3: Basis of Consolidation
ANNEXURE 3 : BASIS OF CONSOLIDATION AHEL Standalone Location Description AHEL Ownership AHEL Chennai Main Chennai Hospital Subsidiaries Location Description Ownership Material Subs ACI - Chennai Chennai Hospital Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarp
Slide 27: Thank You
THANK YOU 26
Apollo Hospitals Enterprise — Q4 FY2022 Earnings Presentation on 6ix